StockNews.com began coverage on shares of Evogene (NASDAQ:EVGN – Free Report) in a report published on Saturday morning. The firm issued a sell rating on the biotechnology company’s stock. Evogene Price Performance EVGN stock opened at $0.72 on Friday. Evogene has a 1-year low of $0.45 and a 1-year high of $1.44. The business has […]